CLBTCellebrite DI Ltd
Slide 1 of 3
Company Overview
Name
Cellebrite DI Ltd
52W High
$26.30
52W Low
$13.10
Market Cap
$4.4B
Dividend Yield
0%
Price/earnings
-1.35
P/E
-1.35
Tags
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$401.2M
Operating Revenue
$401.2M
Total Gross Profit
$338.6M
Total Operating Income
$56.9M
Net Income
$-283M
EV to EBITDA
$0.00
EV to Revenue
$10.20
Price to Book value
$13.16
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$50.9M
Marketing Expense
$132.4M
Research & Development Expense
$98.4M
Total Operating Expenses
$-281.7M
Other Income / (Expense), net
$-332.9M
Total Other Income / (Expense), net
$-332.9M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Cellebrite DI Ltd
52W High
$26.30
52W Low
$13.10
Market Cap
$4.4B
Dividend Yield
0%
Price/earnings
-1.35
P/E
-1.35
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$401.2M
Operating Revenue
$401.2M
Total Gross Profit
$338.6M
Total Operating Income
$56.9M
Net Income
$-283M
EV to EBITDA
$0.00
EV to Revenue
$10.20
Price to Book value
$13.16
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$50.9M
Marketing Expense
$132.4M
Research & Development Expense
$98.4M
Total Operating Expenses
$-281.7M
Other Income / (Expense), net
$-332.9M
Total Other Income / (Expense), net
$-332.9M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Yossi Carmil
Location
N/A, Israel
Exchange
Nasdaq
Website
https://cellebrite.com
Summary
Cellebrite DI Ltd.
Company Info
CEO
Yossi Carmil
Location
N/A, Israel
Exchange
Nasdaq
Website
https://cellebrite.com
Summary
Cellebrite DI Ltd.
Company FAQ
@autobot 2 weeks ago | 2025 - q4
What does this company do? What do they sell? Who are their customers?
Cellebrite DI Ltd. is a leading provider of digital intelligence solutions primarily targeted at law enforcement agencies, government entities, and global enterprises. The company’s core platform enables users to collect, review, analyze, and manage digital data across the entire investigative lifecycle. Its software assists in a range of legal investigations, including cybercrimes, child exploitation, homicide, anti-terrorism operations, border control, and human trafficking. Cellebrite’s clientele is diverse, encompassing law enforcement, border authorities, intelligence services, and private sector forensic teams worldwide. The company positions itself as a vital player in digital forensics and data intelligence, supporting over 7,000 customers globally.
What are the company’s main products or services?
Cellebrite Digital Intelligence (DI) Platform: A unified solution to collect, analyze, and manage digital data during investigations, supporting multiple workflows and comprehensive analysis.,Guardian Suite: An AI-powered investigative platform offering efficient case management, evidence analysis, and workflow automation for law enforcement and other investigative organizations.,Corellium Integration: Advanced mobile virtualization and application analysis technologies, expanding the digital investigation capabilities, especially for mobile platforms.,SaaS Subscription Solutions: Subscription-based digital intelligence tools designed for recurring revenue and high scalability across enterprises and public sector clients.,AI-powered Investigative Tools: Advanced software that leverages artificial intelligence to expedite, scale, and enhance digital analyses, including Guardian Investigate.
Who are the company’s main competitors?
Magnet Forensics,AccessData (now part of Exterro),MSAB (Micro Systemation AB),OpenText (EnCase),Grayshift
What drives the company’s stock price?
Cellebrite's stock price is heavily influenced by its reported earnings results, especially metrics such as revenue growth, Adjusted EBITDA, and guidance on annual recurring revenue (ARR). The company’s rapid transition to SaaS and subscription-based sales has driven increasing recurring revenues and strong gross margins, drawing positive investor sentiment. Additionally, strategic product launches, acquisitions like Corellium, and key wins in the U.S. federal sector act as catalysts. Broader market trends favoring AI and digital intelligence tech stocks provide additional tailwinds. Conversely, reliance on U.S. government contracts and premium valuation introduce volatility and can drive share price fluctuations.
What were the major events that happened this quarter?
In the most recent quarter, Cellebrite reported robust revenue growth, achieving $126 million in revenue (up 18% year-over-year) and a swing to profitability with a $20.2 million net income compared to a significant loss the prior year. The company completed or neared completion of the Corellium acquisition, bolstering its mobile analysis capabilities. There was a substantial increase in subscription sales (21% YoY) and a strong rise in ARR to $440 million. Key leadership changes included the naming of David Barter as new CFO and David Gee as Chief Marketing Officer. The Autumn 2025 Release introduced AI-powered enhancements and expanded platform integrations.
What do you think will happen next quarter?
Looking into the next quarter, Cellebrite is expected to maintain strong momentum in both revenue and ARR growth, projected at $470–$475 million and $460–$475 million respectively for FY2025. The company anticipates completing the Corellium acquisition and leveraging its technology for new verticals and integration within its DI platform. The transition to SaaS is likely to continue driving recurring revenues and improved margin performance. However, management has expressed caution regarding growth from U.S. federal government contracts until at least 2026. Innovations in AI-powered investigative solutions and new product features are likely to be launched to support customer expansion and further differentiate Cellebrite in the market.
What are the company’s strengths?
Cellebrite benefits from a leading market position in digital intelligence for investigations, with a strong global brand recognized by law enforcement and enterprise customers. Its focus on high-margin SaaS and subscription solutions drives recurring revenue and enhances profitability. The company has demonstrated robust customer retention and the ability to cross-sell additional products and enhancements. Recent innovations, including AI-powered investigative tools and the integration of Corellium technology, underscore a commitment to staying ahead in technological advancements. Strategic leadership appointments and a growing customer base further reinforce its competitive edge.
What are the company’s weaknesses?
Despite recent profitability, Cellebrite has historically reported negative earnings and still trades at a premium price-to-book value. Its reliance on large contracts, particularly with U.S. federal agencies, introduces risk if those relationships falter or are delayed. The company’s elevated valuation compared to industry peers may deter some investors, especially if future growth slows. Integration risks from acquisitions and operational challenges in scaling new SaaS offerings also present vulnerabilities. Furthermore, ongoing investments in innovation and expansion may constrain short-term profitability.
What opportunities could the company capitalize on?
Cellebrite stands to benefit from continued demand for digital intelligence solutions as cybercrime and digital evidence become critical in investigations worldwide. The successful integration of Corellium technology opens new possibilities in mobile and app analysis, expanding addressable markets. AI-powered innovation can further streamline investigative processes, helping agencies resolve cases more efficiently and attracting tech-forward customers. Geographic expansion, particularly in underpenetrated regions, could yield significant growth. The shift to SaaS and cloud-based solutions increases scalability and recurring revenue potential, positioning Cellebrite for sustained expansion.
What risks could impact the company?
Cellebrite faces external risks from budgetary pressures or policy changes affecting government procurement, especially in the U.S., its key market. Increasing competition from established and emerging digital forensics vendors could erode market share or pressure pricing. Rapid technological change demands ongoing R&D investment to maintain leadership. The company’s high valuation makes it sensitive to growth shortfalls or market downturns, potentially resulting in sharp share price corrections. Data privacy regulations, geopolitical uncertainties, and dependency on third-party platform integrations also pose ongoing operational and compliance risks.
What’s the latest news about the company?
Recent news highlights include the appointment of new CFO David Barter and CMO David Gee, signaling a focus on financial discipline and global marketing expansion. The company reported strong Q3 results, swinging to profitability and raising full-year guidance for both revenue and profitability. The Autumn 2025 Release featured major product enhancements, including AI-driven analysis and expanded device support. Cellebrite neared the completion of the Corellium acquisition, further strengthening its platform capabilities. Despite these positive developments, shares experienced volatility due to concerns around premium valuation and concentration in U.S. government contracts.
What market trends are affecting the company?
Broader market trends point to increased reliance on digital intelligence and forensics solutions as law enforcement and private entities confront rising volumes of digital evidence. The move towards SaaS and subscription models reflects a demand for scalable, predictable services and has driven valuation premiums for leading software vendors. Advances in AI are transforming how investigations are conducted, with automation and machine learning becoming central differentiators. However, these trends also bring heightened competition, greater scrutiny on data privacy, and more stringent regulatory environments, all influencing operational strategies and shareholder expectations across the sector.
Price change
$18.41
@autobot 8 months ago | 2025 - q2
What does this company do? What do they sell? Who are their customers?
Cellebrite DI Ltd. is a leader in providing digital intelligence solutions for both public and private sectors. Their offerings empower organizations engaged in legally sanctioned digital investigations by delivering advanced tools that collect, review, analyze, and manage digital data throughout the investigative lifecycle. Their platform is used in a wide array of cases, including child exploitation and homicide cases, as well as anti-terrorism efforts, border control, sexual crimes, human trafficking prevention, corporate security, intellectual property theft, and civil litigation. Cellebrite is trusted by major law enforcement agencies worldwide, building a reputation for assisting in complex legal investigations with innovative technology.
What are the company’s main products or services?
Digital Intelligence Platform,Cellebrite Physical Analyzer Ultra Series,Cellebrite Premium SaaS Platform,Cellebrite Government Cloud,Generative AI capabilities in Guardian product
Who are the company’s main competitors?
MSAB,Oxygen Forensics,AccessData,Magnet Forensics,Grayshift
What drives the company’s stock price?
Cellebrite's stock price is influenced by several key factors, including robust earnings growth, particularly in areas like Annual Recurring Revenue (ARR) which saw a 25% increase. Their adjusted EBITDA margins also rose, indicating improved profitability and operational efficiency. Macroeconomic trends like an increased global push towards digitization and cybersecurity drive demand for their solutions, impacting market sentiment positively. Furthermore, favorable developments such as achieving FedRAMP High Ready status highlight technological leadership and secure government contracts, enhancing investor confidence.
What were the major events that happened this quarter?
During the most recent quarter, Cellebrite made significant strides with new introductions like the Cellebrite Physical Analyzer Ultra Series, which supports higher volumes of digital data and enhanced cryptocurrency tracking features. They released a SaaS-based version of Cellebrite Premium, expanding access solutions for customers and reinforcing market leadership. Staffing changes also played a role, with Thomas E. Hogan appointed as Executive Chairman to guide strategic growth. Moreover, they reported strong Q4 2024 financial results with notable growth in revenue and subscription earnings, fulfilling the "Rule of 50" through focused market strategies.
What do you think will happen next quarter?
In the upcoming quarter, Cellebrite is expected to accelerate its competitive positioning by integrating advanced AI technologies across its products. They aim for an ARR growth between 21% to 25%, with revenue expected to grow by 20% to 22%. Continued focus will be on expanding their digital intelligence solutions to meet the sophisticated needs of law enforcement and corporate security, potentially resulting in further market penetration. Potential introductions of innovations to their software offerings could sustain momentum in capturing a growing customer base.
What are the company’s strengths?
Cellebrite's primary strengths lie in its established reputation as a trusted provider of Digital Intelligence solutions, especially among global law enforcement agencies. The company's robust product lineup, including advanced analytics and data collection tools, underpins its market leadership. Strategic leadership additions like Thomas E. Hogan bolster the company’s ability to capitalize on growth opportunities. Its consistent growth in ARR and impressive adjusted EBITDA margins are indicative of operational efficiency and financial health, reinforcing its competitive positioning in a rapidly evolving industry.
What are the company’s weaknesses?
Cellebrite's vulnerabilities include a net loss reported in GAAP terms, which signals an ongoing challenge in achieving profitability despite revenue growth. The highly competitive digital intelligence market presents challenges in maintaining technological leadership and innovation pace. Dependence on legally sanctioned investigations could limit market expansion in certain regions due to differing legal ecosystems. Additionally, the company faces substantial risks inherent in handling sensitive digital information, requiring continuous investment in security measures.
What opportunities could the company capitalize on?
Cellebrite has several lucrative opportunities for growth, including expanding its government and corporate client base with enhanced cloud security solutions like their GovCloud. Their foray into artificial intelligence capabilities holds the promise of elevating analytical functionalities and broadening customer appeal. The elevation of digital forensics and intelligence needs in corporate security presents further market penetration prospects. Additionally, by exploring strategic partnerships and acquisitions, Cellebrite could enhance their market offerings and operational scale, navigating emerging demands from law enforcement security landscapes.
What risks could impact the company?
Cellebrite faces significant risks stemming from rapid technological advancements in digital intelligence, which demand continuous innovation to stay ahead of competitors. The ongoing global scrutiny of digital privacy and ethics presents reputational risks for the company, especially given the sensitive nature of their operations. Market acceptance fluctuates with macroeconomic conditions that affect public budgets and thereby, potential contracts with law enforcement agencies. Competition from newer, disruptive technologies could also undercut existing revenue streams, challenging Cellebrite's market standing.
What’s the latest news about the company?
Recently, Cellebrite made headlines by launching new products like the Cellebrite Physical Analyzer Ultra Series and an SaaS-based Cellebrite Premium, enhancing digital data analysis capabilities. They achieved a significant milestone with their Cellebrite Government Cloud platform securing FedRAMP High Ready status, advancing commitments to U.S. federal cybersecurity. Leadership changes are notable, with Thomas E. Hogan assuming the role of Executive Chairman, succeeding to reinforce strategic oversight. The company continues to emphasize its position through strategic growth and technology innovation, as reflected in their robust Q4 2024 financial results.
What market trends are affecting the company?
The broader digital intelligence market is witnessing an escalating demand driven by growing cyber threats and regulatory requirements enhancing digital investigations. There's a significant shift towards AI integration within forensic tools, aiming for speed and precision in data analysis. The surge in cloud adaptation across public sectors, marked by heightened concerns over data privacy, is pushing companies towards robust, FedRAMP-compliant solutions. Moreover, the increasing complexity of crimes involving digital assets underscores the importance of sophisticated digital intelligence infrastructures, catalyzing market growth.
Price change
$19.01
